Schrodinger Inc. (SDGR) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
1540 BROADWAY NEW YORK, NY 10036 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 463,003 | 451,087 | 576,479 | 642,691 | |||
| Cash and cash equivalents | 155,315 | 90,474 | 120,267 | 202,296 | |||
| Short-term investments | 307,688 | 360,613 | 456,212 | 440,395 | |||
| Restricted cash and investments | 5,751 | 5,243 | 3,000 | 500 | |||
| Receivables | 65,992 | 55,953 | 31,744 | 31,423 | |||
| Prepaid expense | 9,926 | 8,569 | 5,030 | 4,409 | |||
| Other undisclosed current assets | 23,124 | 13,137 | 8,807 | 3,955 | |||
| Total current assets: | 567,796 | 533,989 | 625,060 | 682,978 | |||
| Noncurrent Assets | |||||||
| Operating lease, right-of-use asset | 117,778 | 105,982 | 75,384 | 10,129 | |||
| Property, plant and equipment | (18,150) | 14,244 | 10,025 | 5,140 | |||
| Long-term investments and receivables | 83,251 | 25,683 | 43,167 | 45,664 | |||
| Long-term investments | 83,251 | 25,683 | 43,167 | 45,664 | |||
| Intangible assets, net (including goodwill) | 4,791 | 5,378 | |||||
| Goodwill | 4,791 | 4,791 | |||||
| Intangible assets, net (excluding goodwill) | 587 | ||||||
| Other noncurrent assets | 6,014 | 3,311 | 2,851 | 2,352 | |||
| Other undisclosed noncurrent assets | 41,475 | ||||||
| Total noncurrent assets: | 235,159 | 154,598 | 131,427 | 63,285 | |||
| TOTAL ASSETS: | 802,955 | 688,587 | 756,487 | 746,263 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 60,574 | 39,862 | 33,801 | 23,259 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | 18,405 | 12,000 | ||
| Accounts payable | 16,815 | 9,470 | 8,079 | 8,398 | |||
| Accrued liabilities | 43,759 | 30,392 | 7,317 | 2,861 | |||
| Deferred revenue | 56,231 | 57,931 | 55,368 | 45,403 | |||
| Other undisclosed current liabilities | 16,868 | 11,006 | 2,042 | 4,543 | |||
| Total current liabilities: | 133,673 | 108,799 | 91,211 | 73,205 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation: | 77,827 | 7,221 | |||||
| Liabilities, other than long-term debt | 120,724 | 131,883 | 30,364 | 41,818 | |||
| Deferred revenue | 9,043 | 25,598 | 30,064 | 41,164 | |||
| Other liabilities | 667 | 800 | 300 | 654 | |||
| Operating lease, liability | 111,014 | 105,485 | 77,827 | 7,221 | |||
| Total noncurrent liabilities: | 120,724 | 131,883 | 108,191 | 49,039 | |||
| Total liabilities: | 254,397 | 240,682 | 199,402 | 122,244 | |||
| Equity | |||||||
| Equity, attributable to parent, including: | 548,558 | 447,894 | 557,071 | 624,015 | |||
| Common stock | 607 | ||||||
| Additional paid in capital | 885,973 | 828,700 | 786,964 | 752,558 | |||
| Accumulated other comprehensive income (loss) | 281 | (2,382) | (651) | 317 | |||
| Accumulated deficit | (338,418) | (379,138) | (229,952) | (129,559) | |||
| Other undisclosed equity, attributable to parent | 722 | 714 | 710 | 92 | |||
| Equity, attributable to noncontrolling interest | 11 | 14 | 4 | ||||
| Total equity: | 548,558 | 447,905 | 557,085 | 624,019 | |||
| TOTAL LIABILITIES AND EQUITY: | 802,955 | 688,587 | 756,487 | 746,263 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|---|
| Revenues | 216,666 | 180,955 | 137,931 | 108,095 | ||
| Gain on disposition of assets for financial service operations | 147,213 | |||||
| Cost of revenue | (75,974) | (79,933) | (72,311) | (44,623) | ||
| Gross profit: | 140,692 | 101,022 | 65,620 | 63,472 | ||
| Operating expenses | (318,140) | (247,839) | (177,063) | (124,388) | ||
| Operating loss: | (177,448) | (146,817) | (111,443) | (60,916) | ||
| Nonoperating income (expense) | 220,367 | (2,309) | 10,635 | 34,624 | ||
| Other nonoperating income | 19,693 | 3,950 | ||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 2,174 | |||||
| Income (loss) from continuing operations before equity method investments, income taxes: | 42,919 | (149,126) | (100,808) | (24,118) | ||
| Income (loss) from equity method investments | 147,213 | 11,825 | (1,781) | 4,108 | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (147,213) | (11,825) | 1,781 | (6,282) | ||
| Income (loss) from continuing operations before income taxes: | 42,919 | (149,126) | (100,808) | (26,292) | ||
| Income tax expense (benefit) | (2,199) | (63) | (411) | (345) | ||
| Income (loss) from continuing operations: | 40,720 | (149,189) | (101,219) | (26,637) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (101,219) | (26,637) | |
| Net income (loss): | 40,720 | (149,189) | (101,219) | (26,637) | ||
| Net income attributable to noncontrolling interest | 3 | 826 | 2,174 | |||
| Net income (loss) available to common stockholders, diluted: | 40,720 | (149,186) | (100,393) | (24,463) | ||
Comprehensive Income ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|---|
| Net income (loss): | 40,720 | (149,189) | (101,219) | (26,637) | ||
| Comprehensive income (loss): | 40,720 | (149,189) | (101,219) | (26,637) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 3 | 826 | 2,174 | |||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 2,663 | (1,731) | (968) | 301 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 43,383 | (150,917) | (101,361) | (24,162) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.